This track focuses on the latest research and innovations in neuro oncology, highlighting novel therapeutic approaches and treatment modalities. Participants will explore cutting-edge studies that aim to improve patient outcomes in neuro cancer.

This session will delve into the latest surgical techniques and technologies in neurosurgery for treating brain and spinal cord tumors. Discussions will include minimally invasive approaches and their impact on patient recovery and quality of life.

This track emphasizes the role of advanced neuroimaging techniques in the diagnosis and monitoring of central nervous system malignancies. Experts will present findings on how imaging can enhance treatment planning and patient management.

This session addresses the psychosocial challenges faced by patients with neuro cancer and their families. It aims to foster discussions on supportive care strategies and the importance of mental health in oncology.

This track will present ongoing and completed clinical trials focused on neuro oncology, discussing their methodologies, outcomes, and implications for future research. Participants will gain insights into the challenges and successes of trial design in this field.

This session explores the relationship between neuroinflammation and cancer progression, examining how inflammatory processes can influence tumor behavior. Researchers will discuss potential therapeutic targets within these pathways.

This track highlights the genetic and molecular underpinnings of neuro cancers, focusing on the role of biomarkers in diagnosis and treatment. Presentations will cover recent discoveries in cancer genomics and their clinical applications.

This session investigates the impact of neuro oncology treatments on cognitive function and the prevalence of cognitive disorders among cancer patients. Experts will discuss assessment tools and interventions to support cognitive health.

This track addresses the ethical considerations in neuro oncology research, including informed consent, patient autonomy, and the implications of emerging therapies. Discussions will aim to establish best practices for ethical conduct in clinical trials.

This session focuses on the intersection of vascular neurology and oncology, exploring how vascular conditions can complicate cancer treatment. Participants will discuss strategies for managing these comorbidities in neuro oncology patients.

This track aims to envision the future of neuro oncology, discussing emerging trends, technologies, and research directions. Experts will share their perspectives on the evolving landscape of treatment and care for neuro cancer.